People: Vexim SA (ALVXM.PA)

ALVXM.PA on Paris Stock Exchange

8:40am EDT
Price Change (% chg)

€0.03 (+0.26%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

de la Grange, Bruce 

Brief Biography

Mr. Bruce de la Grange has been Chairman of the Board of Vexim SA since December 2, 2011. Prior to this, he held the functions of Chairman of the Board and Chief Executive Officer of the Company from December 16, 2008. He was previously in charge of development for Plus Orthopedics before it was sold to Smith & Nephew in 2007. He was also Director General at DePuy, for France, Spain and Belgium, and then at Zimmer, where he supervised the European operations. Mr. de la Grange currently also serves as Chief Executive Officer of Bio Novations GmbH. He was Director of the MBA Institute in Paris. He holds a Masters of Business Administration degree from The Wharton School of the University of Pennsylvania.

Basic Compensation

Total Annual Compensation, EUR Long-Term Incentive Plans, EUR All Other, EUR Fiscal Year Total, EUR
50,000 -- -- 50,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks